Logo

ABI Licenses Exiqon's Locked Nucleic Acid IP

Nov 15, 2007
NEW YORK (GenomeWeb News) – Exiqon has granted Applied Biosystems a license to use its locked nucleic acids intellectual property in siRNA projects, the Danish company said today.
 
Exiqon said the agreement fulfills one of its strategic goals for 2008, which was to license its LNA technology to a “major tool provider.” The company said the IP “offers many more possibilities for developing competitive products” than it has the means to pursue.
 
Financial terms of the agreement were not released.

Breaking News
The Scan

Could Cost Billions

NBC News reports that the new Alzheimer's disease drug from Biogen could cost Medicare in the US billions of dollars.

Not Quite Sent

The Biden Administration likely won't meet its goal of sending 80 million SARS-CoV-2 vaccine doses abroad by the end of the month, according to the Washington Post.

DTC Regulation Proposals

A new report calls on UK policymakers to review direct-to-consumer genetic testing regulations, the Independent reports.

PNAS Papers on Mosquito MicroRNAs, Acute Kidney Injury, Trichothiodystrophy

In PNAS this week: microRNAs involved in Aedes aegypti reproduction, proximal tubule cell response to kidney injury, and more.